drugset / Trial / NCT03300518
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
Completed
552 enrolled
Reproductive & Genetic Hospital of CITIC-Xiangya
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of study is to assess the efficacy of add-on estrogen pretreatment in GnRH antagonist protocol on oocyte retrieval as compared with GnRH antagonist protocol for patients with poor ovarian response Add-on estrogen pretreatment protocol is superior to none pretreatment GnRH antagonist protocol for the number of oocytes retrieval
Timeline
- Start
- 2017-11-15
- Primary completion
- 2021-06-18
- Completion
- 2021-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | estradiol valerate | Unknown | 2 mg | Oral |
| Background | Follitropin beta | Protein / enzyme biologic | 300 iu | Subcutaneous |
| Background | Ganirelix | Protein / enzyme biologic | 0.25 mg | — |
| Background | hCG | Unknown | 10000 iu | — |